Sanofi has filed lawsuits in the U.S. District of New Jersey alleging that Pfizer and Moderna violated its mRNA-related patents used in COVID-19 vaccine technology. The legal action adds to a growing portfolio of mRNA IP disputes involving multiple companies competing for ownership claims tied to platform approaches developed during the pandemic era.